Redwood Grove Capital LLC Purchases Shares of 59,070 Humana Inc. $HUM

Redwood Grove Capital LLC purchased a new stake in Humana Inc. (NYSE:HUM) during the second quarter, according to its most recent 13F filing with the SEC. The firm purchased 59,070 shares of the insurance provider’s stock, valued at approximately $23,464,000. Humana makes up 5.9% of Redwood Grove Capital LLC’s holdings, making the stock its 4th largest holding.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Montag A & Associates Inc. raised its stake in shares of Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 94 shares in the last quarter. Johnson Financial Group Inc. acquired a new stake in Humana in the second quarter valued at approximately $26,000. Fideuram Asset Management Ireland dac acquired a new stake in Humana in the fourth quarter valued at approximately $27,000. Trust Co. of Vermont purchased a new position in Humana in the second quarter worth $28,000. Finally, Reflection Asset Management purchased a new position in Humana in the fourth quarter worth $29,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Trading Up 0.6%

NYSE:HUM opened at $388.92 on Wednesday. The company has a market capitalization of $46.70 billion, a P/E ratio of 36.79, a PEG ratio of 2.20 and a beta of 0.72. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $428.88. The firm has a fifty day simple moving average of $383.88 and a 200-day simple moving average of $285.00.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The company had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. During the same quarter last year, the business posted $6.27 EPS. The firm’s quarterly revenue was up 26.2% on a year-over-year basis. On average, equities research analysts anticipate that Humana Inc. will post 9.12 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on HUM. Deutsche Bank Aktiengesellschaft assumed coverage on Humana in a report on Thursday, July 30th. They set a “hold” rating for the company. Barclays boosted their target price on Humana from $344.00 to $407.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Morgan Stanley raised Humana from an “underweight” rating to an “equal weight” rating and upped their target price for the company from $249.00 to $370.00 in a research report on Tuesday, August 4th. Jefferies Financial Group upgraded Humana from a “buy” rating to a “buy” rating in a research note on Wednesday, May 20th. Finally, Oppenheimer reissued an “outperform” rating and issued a $405.00 price target on shares of Humana in a report on Thursday, July 30th. Fourteen research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $403.91.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.